Kennedy disease
MONDO:0010735Kennedy's disease, also known as bulbospinal muscular atrophy (BSMA), is a rare X-linked recessive motor neuron disease characterized by proximal and bulbar muscle wasting.
Also known as: Kennedy disease, Kennedy's disease, SBMA, SMAX1, X-linked BSMA, X-linked bulbospinal amyotrophy, X-linked bulbospinal muscular atrophy, X-linked spinal and bulbar muscular atrophy
18 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Zolgensma's long-term effects under the microscope in new 5-year study
Disease control OngoingThis study follows 175 people with spinal muscular atrophy who previously received the gene therapy Zolgensma in clinical trials. Researchers will monitor them for 5 years to track serious side effects and developmental milestones. The goal is to understand how safe and effective…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
DNA vaccines join forces with keytruda to fight Hard-to-Treat prostate cancer
Disease control OngoingThis phase 2 trial tests whether adding a second DNA vaccine to a standard immunotherapy (pembrolizumab) can improve outcomes for men with castration-resistant metastatic prostate cancer. About 60 participants will receive either one or two DNA vaccines along with pembrolizumab f…
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Global data pooling aims to unlock secrets of rare muscle disease
Knowledge-focused OngoingThis study brings together patient registries from 10 countries to analyze data from 700 people with spinal and bulbar muscular atrophy (SBMA). Researchers will look at changes in muscle function, walking ability, and age of symptom onset. The goal is to better understand how the…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC